Lifeward Ltd. announced on June 24, 2025, a ruling by an Administrative Law Judge (ALJ) in favor of a Medicare beneficiary's appeal, determining that their ReWalk Personal Exoskeleton is 'reasonable and necessary' for Medicare coverage and reimbursement. This ruling establishes a legal basis for the ReWalk system as a medical intervention for paralyzed individuals.
The decision reinforces the clinical basis for the ReWalk technology, supported by scientific literature on the health benefits of ambulation in everyday life. This is a meaningful step in establishing legal precedent for access for those who can benefit from walking again.
This ALJ ruling builds upon the April 2024 decision by the Centers for Medicare & Medicaid Services (CMS) to finalize a Medicare reimbursement pathway for personal exoskeleton use. The ruling is expected to clarify access for Medicare beneficiaries and potentially pave the way for broader coverage through commercial payors.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.